Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Oct 23 2023
Length: 20 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

Listen for free

View show details

Summary
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD.

Related Content:

Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ
Show more Show less

Show more Show less

What listeners say about Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon